DCC-2036 是一种口服生物利用度高的小分子抑制剂,能够抑制多种酪氨酸激酶,具有潜在的抗肿瘤活性。
顾客使用 Adooq 产品发表的高质量科研文献
Adooq用户使用DCC-2036 (Rebastinib)发表的1篇文献
生物活性
Discription | DCC-2036 is an orally bioavailable small-molecule inhibitor of multiple tyrosine kinases with potential antineoplastic activity. |
|||||
---|---|---|---|---|---|---|
Targets |
|
|||||
Cell Research |
|
产品信息
目录号 | A11200 |
---|---|
分子式 | C30H28FN7O3 |
分子量 | 553.59 |
CAS号 | 1020172-07-9 |
SMILES | CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NC)F)C4=CC5=C(C=C4)N=CC=C5 |
其他名称 | DCC2036 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
溶解性数据
In vitro (25°C) | DMSO | 103 mg/mL (186.05 mM) | |
Water | Insoluble | ||
Ethanol | 15 mg/mL (27.09 mM) | ||
In vivo | 0.5% CMC+0.25% Tween 80 | 15 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Preparing Stock Solutions
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 18.06 mL | 90.32 mL | 180.64 mL |
0.5 mM | 3.61 mL | 18.06 mL | 36.13 mL |
1 mM | 1.81 mL | 9.03 mL | 18.06 mL |
5 mM | 0.36 mL | 1.81 mL | 3.61 mL |
Useful Calculator
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
Keywords: 购买 DCC-2036 (Rebastinib) | DCC-2036 (Rebastinib) 供应商 | DCC-2036 (Rebastinib) 花费 | DCC-2036 (Rebastinib) 生产商 | 订购 DCC-2036 (Rebastinib) | DCC-2036 (Rebastinib) 代理商
| 购买 1020172-07-9 | 1020172-07-9 供应商 | 1020172-07-9 花费 | 1020172-07-9 生产商 | 订购 1020172-07-9 | 1020172-07-9 代理商